¹Ù·Î°¡±â ¸Þ´º
ÁÖ¿ä¸Þ´º ¹Ù·Î°¡±â
º»¹® ¹Ù·Î°¡±â
Çϴܸ޴º ¹Ù·Î°¡±â
°Ë»ö

ºñ±Þ¿© Áø·áºñ¾È³»
> Áø·á¾È³» > ºñ±Þ¿© Áø·áºñ¾È³»
Áߺзù :
¸íĪ/ÄÚµå :

ÇàÀ§

  • ÀÇ·á¹ý Á¦45Á¶ µ¿¹ý ½ÃÇà±ÔÄ¢ Á¦42Á¶ÀÇ 2¿¡ ÀÇÇÏ¿© ºñ±Þ¿© Áø·áºñ¿ëÀ» °íÁöÇÕ´Ï´Ù.
ÇàÀ§
Áߺзù ¼ÒºÐ·ù Ç× ¸ñ Áø·áºñ¿ë µî(´ÜÀ§:¿ø) ƯÀÌ»çÇ× ÃÖÁ¾
º¯°æÀÏ
ÄÚµå ¸íĪ ±¸ºÐ ºñ¿ë ÃÖÀú
ºñ¿ë
ÃÖ°í
ºñ¿ë
Ä¡·áÀç·á´ë
Æ÷ÇÔ¿©ºÎ
¾àÁ¦ºñ
Æ÷ÇÔ¿©ºÎ
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã HLA crossmatch °Ëü (KONOS, À§Å¹) 21,000                       20240101
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã °¢¸· °ü¸®ºñ¿ë A(ÀûÃâ+Serology+º¸Á¸¾×) 400,000                       20210401
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã °¢¸· °ü¸®ºñ¿ë B(ÀûÃâ+Sampling+º¸Á¸¾×) 380,000                       20210401
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã °¢¸· °ü¸®ºñ¿ë C(ÀûÃâ+Serology) 360,000                       20210401
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã °¢¸· °ü¸®ºñ¿ë D(ÀûÃâ+Sampling) 330,000                       20210401
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã Àå±â±âÁõÀÚ ¼ø¼ö¼º Æò°¡ »ó´ã 30,000                       20210401
9Á¶ Á¦1Ç×°ü·Ã ºñ±Þ¿© Àå±âÀ̽İü·Ã Àå±âÀ̽Ĵë±âÀÚ µî·Ïºñ 30,000                       20210401

91 92